2-47466718-G-C

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 20 classification points (ACMG Germline Pathogenicity v2019). PS3PM2PM5PP3_StrongPP5_Very_Strong

The NM_000251.3(MSH2):c.1571G>C (p.Arg524Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 9.06). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV004186687: Functional studies indicate this variant impacts protein function [PMID:12124176, 20672385, 28422960]." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R524G: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1775501) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R524C: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 421654); p.R524H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 182564); p.R524L: Uncertain_significance (ClinVar VariationId 90701, 2 stars); p.R524= (synonymous): Likely_benign (ClinVar VariationId 1153022, 2 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: not found (cov: 33)

Consequence

MSH2
NM_000251.3 missense

Scores

15
4

Clinical Significance

Likely pathogenic reviewed by expert panel P:11

Conservation

PhyloP100: 9.06

Publications

1 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000251.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 20 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV004186687: Functional studies indicate this variant impacts protein function [PMID: 12124176, 20672385, 28422960].; SCV000216385: Multiple functional assays have demonstrated that this protein was repair-deficient, unstable, and unable to elicit a DNA checkpoint in response to DNA alkylation damage (Boyer JC et al. Cancer Res. 1995 Dec; 55(24):6063-70; Mastrocola AS et al. Hum. Mutat. 2010 Oct; 31(10):E1699-708; Nielsen SV et al. PLoS Genet. 2017 Apr 19;13(4):e1006739).; SCV000684947: Functional studies have shown that this variant reduces interactions with MSH3 or MSH6 and impairs mismatch repair (MMR) activities (PMID: 8521394, 12124176, 17594722, 20672385).; SCV000322357: "Published functional studies demonstrate a damaging effect: defective mismatch repair, abolishment of the dominant mutator phenotype, deficient ATPase activity, reduced mismatch-binding in vitro and MNNG-induced chromatin-binding in cells, and decreased MMR protein complex assembly (PMID: 8521394, 9774676, 9889267, 10469597, 12124176, 20672385, 33357406)"; SCV000889416: Experimental studies have demonstrated a damaging effect on MSH2 protein function (PMID: 7937795 (1994), 8521394 (1995), 10469597 (1999), 12124176 (2002), 17594722 (2007), 17720936 (2007), 20672385 (2010), 33357406 (2021)).; SCV000625286: Experimental studies have shown that this missense change affects MSH2 function (PMID: 7937795, 10469597, 17594722, 20672385).; SCV000919690: Several publications report experimental evidence evaluating an impact on protein function (e.g. Drotschmann_1999, Heinen_2002, Gammie_2007, Mastrocola_2010).
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00268) — PM2 moderate.
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R524G: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 1775501); Other variants at the same amino acid residue (not pathogenic): p.R524C: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 421654); p.R524H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 182564); p.R524L: Uncertain_significance (ClinVar VariationId 90701, 2 stars); p.R524= (synonymous): Likely_benign (ClinVar VariationId 1153022, 2 stars)
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Strong).
PP5Reputable source reports pathogenic
ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). ClinVar submissions strongly and reliably favor pathogenicity (11/11 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MSH2 NM_000251.3
MANE Select
HGVSc / HGVSpc.1571G>Cp.Arg524Pro
Exon rankExon 10 of 16
missense
Prot: NP_000242.1UniProt: P43246-1
MSH2 NM_001406674.1
HGVSc / HGVSpc.1571G>Cp.Arg524Pro
Exon rankExon 10 of 18
missense
Prot: NP_001393603.1
MSH2 NM_001406631.1
HGVSc / HGVSpc.1571G>Cp.Arg524Pro
Exon rankExon 10 of 18
missense
Prot: NP_001393560.1

Ensembl Transcripts

MSH2 ENST00000233146.7
TSL:1MANE Select
HGVSc / HGVSpc.1571G>Cp.Arg524Pro
Exon rankExon 10 of 16
missense
Prot: ENSP00000233146.2UniProt: P43246-1
MSH2 ENST00000406134.5
TSL:1
HGVSc / HGVSpc.1571G>Cp.Arg524Pro
Exon rankExon 10 of 16
missense
Prot: ENSP00000384199.1UniProt: E9PHA6
MSH2 ENST00000918107.1
HGVSc / HGVSpc.1622G>Cp.Arg541Pro
Exon rankExon 11 of 17
missense
Prot: ENSP00000588166.1UniProt: A0ACI8SWY1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:32
GnomAD4 genome
Cov:33
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
Lynch syndrome (3)
2
-
-
Hereditary cancer-predisposing syndrome (2)
2
-
-
Lynch syndrome 1 (2)
2
-
-
not provided (2)
1
-
-
Hereditary nonpolyposis colon cancer (1)
1
-
-
Hereditary nonpolyposis colorectal neoplasms (1)

Computational Scores

AlphaGenome AVI
Pathogenic31
AlphaMissense
Pathogenic1.0
BayesDel_addAF
Pathogenic0.50D
BayesDel_noAF
Pathogenic0.47
CADD
Pathogenic33
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.85D
Eigen
Pathogenic0.93
Eigen_PC
Pathogenic0.86
FATHMM_MKL
Pathogenic0.99D
FuncVEP CTI
Pathogenic1.0
GPN-Star LLR
N/A-10
GPN-Star score
N/A10
LIST_S2
Uncertain0.97D
M_CAP
Pathogenic0.39D
MetaRNN
Pathogenic0.98D
MetaSVM
Pathogenic0.99D
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Pathogenic3.3M
PhyloP100
Pathogenic9.1
popEVE
Benign-4.0
PrimateAI
Uncertain0.66T
PROVEAN
Pathogenic-6.9D
REVEL
Pathogenic0.94
Sift
Pathogenic0.0D
Sift4G
Uncertain0.0020D
Varity_R
N/A0.99
VESM-3B
Benign-15
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.020
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

1 abnormal
Protein level
MSH2 LOF scores (HAP1)
MSH2 deep mutational scan
Gene
MSH2
Assay type
Cell fitness
Mechanism
DNA and Mismatch repair
Model system
Immortalized human cells (Homo sapiens)
Score
3.33 · p.Arg524Pro (assay numbering)
Classified as
PS3 strongFunctionally abnormalScott calibration: Loss of function
+4 more calibrations
PS3 strongFunctionally abnormalIGVF Coding Variant Focus Group -- Controls: Missense Variants Only: Loss of function
PS3 moderateFunctionally abnormalIGVF Coding Variant Focus Group -- Controls: All Variants: Loss of function
PS3 strongFunctionally abnormalRUO
ExCALIBR calibration (ClinVar 2018): PS3 Strong (6)
PS3 moderate plusFunctionally abnormalRUO
ExCALIBR calibration: PS3 Moderate+ (3)

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.